BIVIBIOVIE INC.

Nasdaq bioviepharma.com


$ 0.50 $ 0.02 (3.42 %)    

Tuesday, 14-May-2024 15:59:55 EDT
QQQ $ 445.88 $ 1.10 (0.25 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.25 (0.43 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 0.499
$ 0.49
$ 0.00 x 0
$ 0.00 x 0
$ 0.49 - $ 0.50
$ 0.45 - $ 7.72
428,051
na
17.63M
$ 7.74
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-12-2024 12-31-2023 10-Q
3 11-08-2023 09-30-2023 10-Q
4 08-16-2023 06-30-2023 10-K
5 05-12-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-Q
7 11-04-2022 09-30-2022 10-Q
8 09-27-2022 06-30-2022 10-K
9 05-11-2022 03-31-2022 10-Q
10 02-08-2022 12-31-2021 10-Q
11 11-10-2021 09-30-2021 10-Q
12 08-30-2021 06-30-2021 10-K
13 05-10-2021 03-31-2021 10-Q
14 01-29-2021 12-31-2020 10-Q
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-K
17 05-13-2020 03-31-2020 10-Q
18 02-13-2020 12-31-2019 10-Q
19 11-19-2019 09-30-2019 10-Q
20 09-27-2019 06-30-2019 10-K
21 05-10-2019 03-31-2019 10-Q
22 02-12-2019 12-31-2018 10-Q
23 11-14-2018 09-30-2018 10-Q
24 10-05-2018 06-30-2018 10-K
25 05-14-2018 03-31-2018 10-Q
26 02-14-2018 12-31-2017 10-Q
27 11-08-2017 09-30-2017 10-Q
28 08-24-2017 06-30-2017 10-K
29 05-09-2017 03-31-2017 10-Q
30 02-07-2017 12-31-2016 10-Q
31 11-16-2016 09-30-2016 10-Q
32 09-28-2016 06-30-2016 10-K
33 05-23-2016 03-31-2016 10-Q
34 02-16-2016 12-31-2015 10-Q
35 11-13-2015 09-30-2015 10-Q
36 10-01-2015 06-30-2015 10-K
37 05-11-2015 03-31-2015 10-Q
38 02-05-2015 12-31-2014 10-Q
39 11-13-2014 09-30-2014 10-Q
40 09-24-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 biovie-presents-data-showing-potential-for-bezisterim-to-reduce-inflammation-and-restore-homeostasis-in-a-manner-correlated-with-alzheimers-disease-and-biomarker-endpoints

"Bezisterim" has been approved as the non-proprietary name for NE3107 Data shows how bezisterim may be restoring homeos...

 biovie-to-present-data-showing-how-ne3107-potentially-restores-homeostasis-via-specific-genes-associated-with-dementia-metabolism-and-inflammation

BioVie Inc. (NASDAQ:BIVI), ("BioVie" or the "Company"), a clinical-stage company developing innovative drug the...

 crude-oil-down-over-1-quoin-pharmaceuticals-shares-spike-higher

U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to ...

 why-bitdeer-technologies-shares-are-trading-higher-by-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported prelimina...

 gold-gains-1-joann-shares-plummet

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 0.2% on Monday. The Dow traded down ...

 why-biovie-bivi-shares-are-down-40

BioVie shares are trading lower by 42% during Monday's session. The company announced the pricing of its public offering.

 dow-falls-over-100-points-sea-posts-upbeat-sales

U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market openin...

 why-biovie-shares-are-trading-lower-by-around-42-here-are-20-stocks-moving-premarket

Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public ...

 biovie-prices-21m-public-offering-includes-shares-and-warrants-at-1-each

BioVie Inc. (NASDAQ:BIVI), ("BioVie" or the "Company"), a clinical-stage company developing innovative drug the...

 crude-oil-rises-over-2-fisker-shares-plummet

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded ...

 why-zscaler-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

 nasdaq-surges-100-points-ism-manufacturing-pmi-falls-in-february

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow trade...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION